N2-Isobutyryl-5′-O-(4,4′-dimethoxytrityl)-2′-deoxyguanosine
(Synonyms: 5'-O-(4,4'-二甲氧基三苯基)-N2-异丁酰基-2'-脱氧鸟甙,N2-Isobutyryl-5′-O-(4,4′-dimethoxytrityl)-2′-deoxyguanosine) 目录号 : GC47730A building block
Cas No.:68892-41-1
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
N2-Isobutyryl-5′-O-(4,4′-dimethoxytrityl)-2′-deoxyguanosine is a building block that has been used in the synthesis of oligodeoxyribonucleotides.1,2,3
1.Wilk, A., Grajkowski, A., Phillips, L.R., et al.The 4-[N-Methyl-N-(2,2,2-trifluoroacetyl)amino]butyl group as an alternative to the 2-cyanoethyl group for phosphate protection in the synthesis of oligodeoxyribonucleotidesJ. Org. Chem.64(20)7515-7522(1999) 2.Grajkowski, A., Pedras-Vasconcelos, J., Wang, V., et al.Thermolytic CpG-containing DNA oligonucleotides as potential immunotherapeutic prodrugsNucleic Acids Res.33(11)3550-3560(2005) 3.Cie?lak, J., and Beaucage, S.L.Thermolytic properties of 3-(2-pyridyl)-1-propyl and 2-[N-methyl-N-(2-pyridyl)]aminoethyl phosphate/thiophosphate protecting groups in solid-phase synthesis of oligodeoxyribonucleotidesJ. Org. Chem.68(26)10123-10129(2003)
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.5632 mL | 7.8162 mL | 15.6323 mL |
5 mM | 0.3126 mL | 1.5632 mL | 3.1265 mL |
10 mM | 0.1563 mL | 0.7816 mL | 1.5632 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。